cyclosporine has been researched along with A-alphalipoprotein Neuropathy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burnett, JR; Gaus, K; Guo, DL; Jessup, W; Kay, J; Kockx, M; Kritharides, L; Le Goff, W; Rentero, C; Stow, JL; Traini, M; Van Eck, M; Wimmer-Kleikamp, S | 1 |
1 other study(ies) available for cyclosporine and A-alphalipoprotein Neuropathy
Article | Year |
---|---|
Cyclosporin A decreases apolipoprotein E secretion from human macrophages via a protein phosphatase 2B-dependent and ATP-binding cassette transporter A1 (ABCA1)-independent pathway.
Topics: Animals; Apolipoproteins E; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Calcineurin; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP-Dependent Protein Kinases; Cyclosporine; Endoplasmic Reticulum; Humans; Hyperlipidemias; Immunosuppressive Agents; Kinetics; Macrophages; Models, Biological; Tangier Disease | 2009 |